...
首页> 外文期刊>Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry >Interaction between adenosine A 2B-receptors and alpha2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform.
【24h】

Interaction between adenosine A 2B-receptors and alpha2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform.

机译:腺苷A 2B受体和α2肾上腺素受体之间的相互作用对大鼠输精管中去甲肾上腺素释放的调节:可能涉及第2组腺苷酸环化酶同工型。

获取原文
获取原文并翻译 | 示例
           

摘要

In the prostatic portion of rat vas deferens, activation of adenosine A 2B-receptors, beta2-adrenoceptors, adenylyl cyclase or protein kinase A caused a facilitation of noradrenaline release. Blockade of alpha2-adrenoceptors with yohimbine (1 microM) attenuated the facilitation mediated by adenosine A 2B-receptors and by direct activation of adenylyl cyclase with forskolin but not that mediated by beta2-adrenoceptors or by direct activation of protein kinase A with 8-bromoadenosine-3',5'-cyclicAMP. The adenosine A 2B- and the beta2-adrenoceptor-mediated facilitation was prevented by the adenylyl cyclase inhibitors, 2',5'-dideoxy-adenosine (3 microM) and 9-cyclopentyladenine (100 microM), at concentrations that also attenuated the release enhancing effect of forskolin, but were not changed by the phospholipase C inhibitor 1-[6-[((17beta)-3-methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-1H-pyrro le-2,5-dione (U-73122, 1 microM). Facilitation of noradrenaline release mediated by adenosine A 2B-receptors was also attenuated by activation of protein kinase C with the phorbol ester 12-myristate 13-acetate (1 microM) and by inhibition of Gbetagamma subunits with an anti-betagamma peptide; facilitation mediated by beta2-adrenoceptors was mainly attenuated by the calmodulin inhibitor calmidazolium (10 microM) and by the calmodulin kinase II inhibitor (N-[2-[N-(4-chlorocinnamyl)-N-methylaminomethyl]phenyl]-N-(2-hydroxyethyl) -4-methoxybenzene-sulfonamide phosphate (KN-93, 5 microM). The results suggest that adenosine A 2B- but not beta2-adrenoceptor-mediated facilitation of noradrenaline release is enhanced by an ongoing activation of alpha2-adrenoceptors. They further suggest that adenosine A 2B-receptors and beta2-adrenoceptors are coupled to distinct adenylyl cyclase isoforms what may explain the different influence of alpha2-adrenoceptor signalling pathway on the facilitatory effects mediated by the two adenylyl cyclase coupled receptors.
机译:在大鼠输精管的前列腺部分,腺苷A 2B受体,β2-肾上腺素受体,腺苷酸环化酶或蛋白激酶A的激活引起去甲肾上腺素释放的促进。用育亨宾(1 microM)阻断α2肾上腺素受体可减弱腺苷A 2B受体介导的促成作用,并通过用福司可林直接激活腺苷酸环化酶,而不是通过β2肾上腺素受体介导的促成作用,或通过用8-溴腺苷直接激活蛋白激酶A介导的促成作用。 -3',5'-循环AMP。腺苷酸环化酶抑制剂2',5'-二脱氧腺苷(3 microM)和9-环戊基腺嘌呤(100 microM)阻止了腺苷A 2B和β2-肾上腺素受体介导的促进作用,其浓度也减弱了释放增强了佛司可林的作用,但未被磷脂酶C抑制剂1- [6-[((17β)-3-甲氧基estra-1,3,5 [10] -trien-17-yl)氨基]己基] -1H改变-吡咯le-2,5-dione(U-73122,1 microM)。腺苷A 2B受体介导的去甲肾上腺素释放的促进作用也被佛波酯12-肉豆蔻酸酯13-乙酸酯(1 microM)激活蛋白激酶C以及通过抗β-γ肽抑制Gbetagamma亚基而减弱。 β2-肾上腺素受体介导的促进作用主要被钙调蛋白抑制剂Calidazolium(10 microM)和钙调蛋白激酶II抑制剂(N- [2- [N-(4-氯肉桂基)-N-甲基氨基甲基]苯基] -N-( (2-羟乙基)-4-甲氧基苯磺酰胺磷酸酯(KN-93,5 microM)。结果表明,腺苷A 2B-而不是β2-肾上腺素受体介导的去甲肾上腺素释放的促进作用通过不断活化的α2-肾上腺素受体而增强。他们进一步表明,腺苷A 2B受体和β2-肾上腺素受体与不同的腺苷酸环化酶同工型偶联,这可能解释了α2-肾上腺素受体信号通路对两个腺苷酸环化酶偶联受体介导的促进作用的不同影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号